Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
Clinical trial NCT04782323 · COMPLETED
Trial details
- NCT number
- NCT04782323
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-13
- Primary completion
- 2021-09-22
- Enrollment
- 839
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.